Board Certifications
  American Board of Internal Medicine

American Board of Internal Medicine, Infectious Disease

 
 
Appointments
 
                    
 
Weill Cornell \r\nPhysician
   

Vogler, Mary A.
 (212) 746-7200  (212) 746-7166

Bibliography:
1.Kelker HC, Seidlin M, Vogler M, Valentine FT. Lymphocytes from some long-term seronegative heterosexual partners of HIV-infected individuals proliferate in response to HIV antigens. AIDS Res & Hum Retrov 1992; 8:1355-59.
2.Seidlin M, Vogler M, Lee E, Lee YS, Dubin N. Heterosexual transmission of HIV in a cohort of couples in New York City. AIDS 1993; 7:1247-54.
3.Santos MR, Gandhi S, Vogler M, Hanna B, Holzman R. Suspected diphtheria in an Uzbek national: Isolation of Corynebacterium pseudodiphtheriticum resulted in a false-positive presumptive diagnosis. Clin Infect Dis 1996; 22:735.
4.Marmor M, Titus S, Harrison C, Cord-Cruz EA, Shore RE, Vogler M, et al. Weight loss is associated with HIV seroconversion among injection drug users. JAIDS, 1996;12 (5):514-18.
5.Anderson J, Clark R, Watts DH, Till M, Arrastia C, Schuman P, Cohn SE, Young M, Bessen L, Greenblatt R, Vogler M, Swindells S, Boyer P. Idiopathic genital ulcers in women infected with human immunodeficiency virus. JAIDS, 1996; 13 (4):343-347.
6.Niu MT, Bethel J, Holodniy M, Standiford HC, Schnittman S, Datri 002 Study Group. Zidovudine Treatment in Patients with Primary (Acute) HIV infection: A Randomized Double-Blind, Placebo-Controlled Trial. JID 1998; 178:80-9.
7.Williams FS, Roure RM, Till M, Vogler M, DelPriore G: Treatment of Cervical Carcinoma in Situ in HIV Positive Women, Int J of Gyn & Ob, 2000 Nov: 71 (2): 135 ? 9.
8.Braun J, el-Sadr W, Merrick S, Rubin D, Vogler M, Frost KR: Clinicians? Discussion: Trends in HIV Care, AIDS Reader, 2000 Apr 1- ( 4):233 -40.
9.Vogler MA, Teppler H, Gelman R, Valentine F, Lederman,M M, Pomerantz, RJ, Pollard, RB, WengCherng, D, Gonzalez, CJ, Squires, KE, Frank, I, Mildvan D, Mahon, LF, Schock, B, and the ACTG 248 Study Group: Daily Low-Dose Subcutaneous Interleukin-2 (IL-2) Added to Single or Dual Nucleoside therapy in HIV Infection Does Not Protect Against CD4+T Cell Decline or Improve Other Indices of Immune function: Results of a Randomized Clinical Trial ( ACTG 248). JAIDS, 36(1) 576-587, 2004.
10.Achkar JM, Burda ST, Konings FAJ, Urbanski MM, Williams CAU, Seifen D, Kahirimbanyi MN, Vogler M, Parta M, Lupatkin HC, Zolla-Pazner S, Nyambi, PN: Infection with HIV Type 1 Group M Non-B Subtypes in Individuals Living in New York City, JAIDS, 36( 3) 835 ? 844, 2004.
11.Marmor M, Hertzmark K, Thomas SM, Halkitis PN, Vogler M: Resistance to HIV Infection, Journal of Urban Health: Bulletin of the New York Academy of Medicine, 83(1),2006.
12.Vogler MA: Update: Preventing Mother-to-Child Transmission of HIV, Current HIV/AIDS Reports 2006; 3:59-65,2006.
13.Vogler MA: A New Heterogenous Liver Mass in a Patient with Well-Controlled HIV and HBV. AIDS Reader, 2006; 16: 393-396, 401-402.
14.Vogler MA: Pregnancy in a Perinatally Infected Woman: Preventing Second-Generation Mother-to-Child Transmission of HIV. AIDS Reader, 2007; 17.
15.Volberding P, Connick E, Bosch R, Aga E, Pettinelli C, Hirsch M, Vogler M, Little S, Demeter L and the AIDS clinical Trials Group, Interrupted Antiretroviral Therapy of Acute Compared to Recent HIV Infection: Final Results of ACTG 371, Accepted for Presentation at CROI 2008, Feb 3 ? 7, 2008, Boston, MA.
   
   
 

Weill Cornell Physicians

 
 
                    
 
Top Back to Top
NewYork-Presbyterian